Pediatrix Medical Group (NYSE:MD) Price Target Raised to $18.00

Pediatrix Medical Group (NYSE:MD) had its price objective boosted by Truist Financial from $15.00 to $18.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Truist Financial’s price target indicates a potential upside of 11.01% from the stock’s current price.

Several other research firms have also recently issued reports on MD. Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Jefferies Financial Group increased their price target on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. UBS Group increased their price target on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $16.75.

Pediatrix Medical Group Stock Performance

NYSE MD traded down $1.02 during trading hours on Friday, hitting $16.22. The company had a trading volume of 498,678 shares, compared to its average volume of 531,748. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. The business has a fifty day simple moving average of $13.86 and a 200-day simple moving average of $12.91. The firm has a market cap of $1.39 billion, a P/E ratio of -5.31, a price-to-earnings-growth ratio of 1.43 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The company had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Equities analysts predict that Pediatrix Medical Group will post 1.26 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of MD. State Street Corp boosted its position in shares of Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after purchasing an additional 50,597 shares during the period. Nordea Investment Management AB boosted its position in shares of Pediatrix Medical Group by 51.6% in the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock valued at $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC boosted its position in shares of Pediatrix Medical Group by 302.9% in the 3rd quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after purchasing an additional 106,817 shares during the period. Franklin Resources Inc. acquired a new position in shares of Pediatrix Medical Group in the 3rd quarter valued at $598,000. Finally, Principal Financial Group Inc. boosted its position in shares of Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after purchasing an additional 63,581 shares during the period. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.